Alligator Bioscience AB (publ) (STO:ATORX)
0.0249
-0.0008 (-3.11%)
Sep 4, 2026, 12:05 PM CET
Alligator Bioscience AB Market Cap
Alligator Bioscience AB has a market cap or net worth of 16.14 million as of September 3, 2026. Its market cap has decreased by -89.11% in one year.
Market Cap
16.14M
Enterprise Value
29.45M
Revenue
681.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.02
ChartMarket Cap Chart
Since November 23, 2016, Alligator Bioscience AB's market cap has decreased from 2.67B to 16.14M, a decrease of -99.39%. That is a compound annual growth rate of -40.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 16.14M | 9.36% |
| Dec 30, 2025 | 14.76M | -92.20% |
| Dec 30, 2024 | 189.17M | -58.27% |
| Dec 29, 2023 | 453.33M | 32.59% |
| Dec 30, 2022 | 341.91M | -39.69% |
| Dec 30, 2021 | 566.90M | -0.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Nov 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| OncoZenge AB | 65.53M |
| AcouSort AB | 63.07M |
| Pila Pharma AB | 62.36M |
| Modus Therapeutics Holding AB | 62.16M |
| Fluicell AB | 42.17M |
| ExpreS2ion Biotech Holding AB | 33.60M |
| Aptahem AB | 13.95M |
| NanoEcho AB | 13.18M |